IA
MIRM icon

IFP Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

IFP Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.92K Hold
42
– – ﹤0.01% 3804
2026
Q1 		$3.88K Hold
42
– – ﹤0.01% 3670
2025
Q4 		$3.32K Hold
42
– – ﹤0.01% 3630
2025
Q3 		$3.08K Hold
42
– – ﹤0.01% 3503
2025
Q2 		$2.14K Buy
+42
New +$1.87K ﹤0.01% 3874
2025
Q1 		– Sell
-3
Closed -$124 – 4521
2024
Q4 		$124 Buy
+3
New +$125 ﹤0.01% 3956

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's MIRM Position: Q2 2026 in Review

IFP Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 42 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #3804.

IFP Advisors first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • IFP Advisors held 42 shares of Mirum Pharmaceuticals worth $4.92K as of Q2 2026.
  • IFP Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3804 holding.
  • IFP Advisors first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.